Chinook Therapeutics
KDNY
$40.39
Share price
0.00%
Change (1 day)
109.71%
Change (1 year)
Categories
EPS for Chinook Therapeutics (KDNY)
EPS in 2023 (TTM): -$3.52
According to Chinook Therapeutics's latest financial reports the company's current EPS (TTM) is -$3.52. In 2022 the company made an earnings per share (EPS) of -$2.88 a decrease over its 2021 EPS that were of -$2.39.
EPS history for Chinook Therapeutics from 2020 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$3.52 | 22.22% |
| 2022 | -$2.88 | 20.5% |
| 2021 | -$2.39 | 19.97% |
| 2020 | -$1.99 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$2.18 | -38.07% | 🇺🇸 USA |